National Center for Tumor Diseases (NCT) Heidelberg
Katharina Hilse is currently working as a Clinical Study Coordinator at the National Center for Tumor Diseases (NCT) in Heidelberg. Prior to this role, Katharina was also a Clinical Study Coordinator at the Department of Clinical Pharmacology and Pharmacoepidemiology at the University Hospital Heidelberg. With a background as a Paediatric Nurse in various departments including Paediatric Cardiology and Paediatric Oncology and Hematology, Katharina has a strong foundation in nursing. Katharina holds a Master of Clinical Research from Universität für Weiterbildung Krems and a degree as a Graduate Paediatric Nurse from the School of Nursing at the University of Schleswig-Holstein.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.